Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Espionage Scandal Rocks TSMC as U.S. Operations Face Profit Collapse

Robert Sasse by Robert Sasse
November 20, 2025
in Analysis, Mergers & Acquisitions, Semiconductors, Tech & Software
0
TSMC Stock
0
SHARES
123
VIEWS
Share on FacebookShare on Twitter

Taiwan Semiconductor Manufacturing Company (TSMC), the world’s leading chipmaker, finds itself navigating dual crises as a major corporate espionage investigation unfolds alongside severe profitability challenges at its American facilities.

Former Executive Accused of Stealing Critical Secrets

Taiwanese prosecutors have launched a formal investigation into former TSMC vice president Lo Wei-jen, who stands accused of removing over 80 boxes containing highly sensitive technical documents after 21 years with the company. The materials allegedly included proprietary information about TSMC’s groundbreaking 2-nanometer, A16, and A14 process technologies. Adding to concerns, Lo unexpectedly joined U.S. competitor Intel in late October, raising suspicions that critical semiconductor secrets may have been transferred to a direct rival.

The case has escalated to involve Taiwan’s Ministry of Economic Affairs, which is examining potential violations of the National Security Law. This development underscores the intense technological competition within the global semiconductor sector and highlights the strategic importance of chip manufacturing to Taiwan’s industrial development.

American Operations Report Dramatic Earnings Decline

While TSMC recently celebrated the symbolic production of its first Nvidia Blackwell wafer in Arizona, financial reports revealed a starkly different story. The company’s U.S. subsidiary experienced a devastating 99% profit collapse during the third quarter, plummeting from $4.2 billion to a mere $1.3 million. Company officials attribute this dramatic downturn to typical startup challenges, including elevated initial operating expenses, significant employee training costs, and an underdeveloped local supply chain.

Should investors sell immediately? Or is it worth buying TSMC?

Despite these setbacks, the American operations represent only a minor portion of TSMC’s overall business. The parent company reported strong operational profits of 500.7 billion Taiwanese dollars during the same quarter, reflecting an 8% increase from the previous quarter.

Market Analysts Maintain Confidence in TSMC’s Position

Leading financial institutions continue to express optimism about TSMC’s long-term prospects despite current challenges. Bank of America has reaffirmed its buy rating for TSMC shares with a price target of $390. Market experts point to the company’s dominant position in advanced semiconductor manufacturing and its commitment to capacity expansion, evidenced by a budgeted $14.98 billion for facility development.

The banking institution projects TSMC will maintain gross margins around 60% through 2027, supported by its market leadership and sustained demand for artificial intelligence technologies. Although revenue growth moderated to 16.9% year-over-year in October, compared to 31.4% in September, the overall financial outlook remains positive.

Critical Tests Ahead for Semiconductor Leader

The fourth quarter earnings report scheduled for January 2026 will serve as a crucial indicator of TSMC’s ability to overcome its current challenges. This disclosure will reveal whether the company has successfully addressed profitability issues in its U.S. operations and whether the espionage investigation has materially impacted business performance. Despite facing significant headwinds, TSMC maintains a fundamentally strong market position, with AI-driven demand continuing to fuel utilization rates at its most advanced manufacturing facilities.

Ad

TSMC Stock: Buy or Sell?! New TSMC Analysis from February 7 delivers the answer:

The latest TSMC figures speak for themselves: Urgent action needed for TSMC investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

TSMC: Buy or sell? Read more here...

Tags: TSMC
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock
Gaming & Metaverse

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
Texas Instruments Stock

Analyst Sentiment Sours on Texas Instruments Amid Weakening Outlook

AbbVie Stock

AbbVie's Strategic Pivot Gains Momentum with Regulatory Win

Innodata Stock

Innodata Stock: Navigating the AI Surge Amid Market Volatility

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com